Company Filing History:
1 out of 7 
1 out of 12 Years Active: 2024
Title: Minju Lee: Innovator in Antibody-Drug Conjugates
Introduction
Minju Lee, an accomplished inventor hailing from Daejeon, South Korea, has made significant contributions to the field of biomedical research. With a singular patent to his name, Lee's work focuses on the development of antibody-drug conjugates, which are essential in targeted cancer therapies.
Latest Patents
Minju Lee's notable patent is titled "Antibody-drug conjugates comprising anti-B7-H3 antibodies." This patent describes innovative antibody-drug conjugates (ADCs) wherein one or more active agents are conjugated to an anti-B7-H3 antibody via a linker. The linker plays a crucial role as it covalently binds the active agents to the antibody. This patent further encompasses monoclonal antibodies, antigen-binding fragments, variants, and bispecific versions that specifically target B7-H3. Moreover, it discusses various methods for manufacturing and utilizing these anti-B7-H3 antibodies in therapeutic, diagnostic, and preventive applications.
Career Highlights
Throughout his career, Minju Lee has collaborated with pioneering companies such as Intocell, Inc. and Y-Biologics Inc. His work within these organizations has helped propel advancements in the understanding and application of antibody-drug conjugates, positioning him as a name to watch in the realm of biomedicine.
Collaborations
Lee has notably worked alongside talented professionals like Taekyo Park and Sunyoung Kim. Their collective expertise has fostered a dynamic research environment that encourages innovation and scientific discovery in the field of antibody-drug conjugates.
Conclusion
Minju Lee's contributions to the field of biotechnology, particularly through his patent on anti-B7-H3 antibody-drug conjugates, represent a critical advancement in targeted therapies. His ongoing collaborations and work at prominent research institutions and companies reflect his commitment to developing effective treatment solutions, making him a notable inventor in the realm of biomedical innovations.